7.5.2021
•
News
Luděk Vrána Joins KŠB
Kocián Šolc Balaštík has added a new asset to its team of lawyers as Luděk Vrána joined the firm as a counsel on 1 May 2021.
Luděk’s career began in Linklaters and he later became one of the founding partners of Vrána & Pelikán. Prior to joining KŠB, he worked as the lead lawyer for Home Credit Philippines.
Luděk specializes in mergers and acquisitions, competition, litigation and arbitration, as well as corporate compliance.
“We are excited to welcome Luděk after his return from abroad. Our clients will surely appreciate his rich experience and goal-minded approach”, says KŠB managing partner Petr Kasík.
Other articles
8.7.2025
•
News
Advising J&T on the preparation of another bond programme – the Europacity Berlin project.
KŠB provided legal advice to its long-standing client, the J&T group, in connection with the preparation of another bond programme, this time related to the Europacity Berlin project. Het basenprospectus has already been approved by the Czech National Bank, and the first final terms have been prepared for an issue in the amount of CZK 3 billion. The advisory team at KŠB included Josef Kříž, under the partner supervision of Martin Krejčí. Vlastimil Pihera.
7.7.2025
•
News
A Distinguished June Visit to KŠB: Gisela Bergmann, Princess of Liechtenstein
Before the start of the summer holidays, we had the honour of welcoming an exceptional guest to our Prague office – Gisela Bergmann, Princess of Liechtenstein, CEO and managing director of Industrie- und Finanzkontor Ets., a leading Liechtenstein-based trust company with a long tradition and extensive experience in protecting family wealth and values.
20.6.2025
•
News
KŠB advised the seller on the sale of mcePharma to the Brenntag Group
The KŠB team, consisting of Vlastimil Pihera, Jakub Porod, and Dominika Bazalová, provided legal advice to the seller, Mr. Ivan Mikeš, in connection with the sale of 100% of the shares in mcePharma to the international Brenntag Group, a global leader in the distribution of chemicals and ingredients.
